TrialThe Lancet. Oncology2019

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.

John N Primrose et al.PubMed ↗Publisher ↗

No numbers read from the abstract.